Simplex Trading
CARM

Simplex Trading’s Carisma Therapeutics CARM Stock Holding History

Simplex Trading’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,037
Closed -$28.5K – 10445
2021
Q4 		$33K Sell
2,037
-4,709
-70% -$94.8K ﹤0.01% 7763
2021
Q3 		$609K Buy
6,746
+77
+1% +$3.69K ﹤0.01% 3789
2021
Q2 		$616K Sell
6,669
-265
-4% -$16.9K ﹤0.01% 3830
2021
Q1 		$360K Buy
6,934
+4,539
+190% +$214K ﹤0.01% 3880
2020
Q4 		$64K Buy
+2,395
New +$60.7K ﹤0.01% 5905
2020
Q2 		– Sell
-920
Closed -$12.4K – 7648
2020
Q1 		$10K Buy
920
+497
+117% +$8.14K ﹤0.01% 6457
2019
Q4 		$8K Buy
423
+18
+4% +$414 ﹤0.01% 6482
2019
Q3 		$9K Buy
+405
New +$9.48K ﹤0.01% 6290
2019
Q2 		– Sell
-1
Closed -$30 – 7125
2019
Q1 		$0 Buy
+1
New +$17 ﹤0.01% 7161
2018
Q2 		– Sell
-1,721
Closed -$75.8K – 7378
2018
Q1 		$36K Buy
+1,721
New +$33K ﹤0.01% 2746

Other funds holding CARM

TOTUOP
Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $297M AUM
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
Deuterium Capital Management Clearwater, Florida $86M AUM 87.31% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Simplex Trading's CARM Position: Q1 2022 in Review

Simplex Trading sold out of Carisma Therapeutics (CARM) in Q1 2022, closing a stake of 2,037 shares — an estimated $28.5K sold.

Simplex Trading first reported a position in CARM in Q1 2018 and held it in 10 quarters. The position peaked at $616K in Q2 2021. 84 funds tracked by Wall St. Rank hold CARM as of Q1 2022.

  • Simplex Trading reported no remaining Carisma Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Simplex Trading sold 2,037 Carisma Therapeutics shares in Q1 2022, an estimated $28.5K.
  • Simplex Trading first reported a position in Carisma Therapeutics in Q1 2018 and held it in 10 quarters.
  • Simplex Trading's Carisma Therapeutics position peaked at $616K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2022.

Based on Simplex Trading's 13F filing for Q1 2022, filed 2 May 2022.